Results 1 to 10 of about 1,535,020 (310)

Pharmacoeconomic efficacy of atesolizumab compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy

Фармакоэкономика, 2020
Aim: to evaluate the pharmacoeconomic efficacy of the application of the atesolizumab (PD-L1 inhibitor) preparation compared with other control point inhibitors (PD-1 inhibitors) in patients with advanced non-small cell lung cancer (NSCLC) after chemothe
S. K. Zyryanov, I. N. Diyakov
doaj   +1 more source

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects

Эпидемиология и вакцинопрофилактика, 2020
Relevance. Vaccination of people at high risk against pneumococcal infection with a 13-valent conjugate vaccine (PCV13) can significantly reduce the corresponding incidence and mortality.The aim of the work was to assess the pharmacoeconomic aspects of ...
A. V. Rudakova, S. M. Kharit, Yu. V. Lobzin   +2 more
doaj   +1 more source

The impact of patent expiry on drug prices: insights from the Dutch market

Journal of Market Access & Health Policy, 2021
Background: Currently literature on the impact of patent expiry on drug prices is lacking. Objective: To determine the impact of patent expiration and generic entry on drug prices in the Netherlands.
Simon van der Schans, Gert T. Vondeling, Qi Cao, Simon van der Pol, Sipke Visser, Maarten J. Postma, Mark H. Rozenbaum   +6 more
doaj   +1 more source

Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries

Frontiers in Pharmacology, 2022
Background: Nusinersen is an orphan drug intended for the treatment of spinal muscular atrophy (SMA), a severe genetic neuromuscular disorder. Considering the very high costs of orphan drugs and the expected market entry of cell and gene therapies, there
Alessandra Blonda, Teresa Barcina Lacosta, Mondher Toumi, Steven Simoens   +3 more
doaj   +1 more source

The UK public finances: ready for recession? [PDF]

, 2008
Summary Neither the current Labour government nor the previous Conservative one can look back over their respective terms of office as periods of great success in fiscal management.
Chote, R., Emmerson, C., Tetlow, G.
core   +1 more source

Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Singapore Healthcare System Perspective

ClinicoEconomics and Outcomes Research, 2022
Xiao Jun Wang,1 Yi-Ho Wang,2 Matthew Jian Chun Ong,1 Christina Gkitzia,3 Shui Yen Soh,4 William Ying Khee Hwang5– 7 1Novartis Singapore Pte Ltd, Singapore; 2Novartis Asia Pacific Pharmaceuticals Pte Ltd, Singapore; 3Novartis Pharma AG, Basel, Switzerland;
Wang XJ, Wang YH, Ong MJC, Gkitzia C, Soh SY, Hwang WYK   +5 more
doaj  

Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan

Фармакоэкономика, 2019
The integrated Model of health care for patients with inflammatory bowel disease (IBD) is based on the creation of specialized centers where multidisciplinary teams provide patient-centered care.
T. P. Bezdenezhnykh, D. V. Fedyaev, G. R. Khachatryan, G. G. Arutyunov, K. V. Gerasimova   +4 more
doaj   +1 more source

Lifelong vaccination model: for a better quality of life

Biotechnology & Biotechnological Equipment, 2023
Vaccination is one of the most powerful and affordable means in the history of public health. It is the most effective method of preventing infectious diseases, as immunizations save millions of people from disease, disability and death each year ...
Radka Argirova, Albena Zlatareva
doaj   +1 more source

Budget impact of vildagliptin

Farmeconomia. Health economics and therapeutic pathways, 2008
Introduction: to evaluate the impact on the Italian National Health Service (NHS) budget of the recent introduction of the DPP-4 inhibitor vildagliptin in combination treatment for NIDDM patients. Methods: NIDDM patients eligible to vildagliptin treatment were identified and quantified based on approved indications and prevalence data review; adequate ...
Orietta Zaniolo, Viola Sacchi, Lorenzo Pradelli   +2 more
openaire   +3 more sources

Evaluation of peer recovery services for substance use disorder in Minnesota: Impact of peer recovery initiation on SUD treatment and recovery

Drug and Alcohol Dependence Reports
Substance use disorder (SUD) remains one of the most persistent public health challenges across the nation and in Minnesota. One intervention to help people with SUD is peer recovery services (PRS).
Cody R. Tuttle, Aaron T. Berger, Sean L. Barton, Ben Nguyen, Weston Merrick   +4 more
doaj   +1 more source